IDX.ASX: Preliminary FY26 Results and Appointment of New CFO

Preliminary FY26 Results and Appointment of New CFO

Stock	Integral Diagnostics Ltd (IDX.ASX)
Release Time	10 Aug 2026, 9:05 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Integral Diagnostics Ltd FY26 Results and New CFO

Key Points

Preliminary FY26 revenue expected at $788m-$790m, up ~25%
Operating EBITDA anticipated at $164m-$165m, up ~30%
New CFO Ms Jenny Martin to join on October 5, 2026
Current CFO Mr Craig White to retire on April 30, 2027
Audited FY26 results to be released on August 25, 2026

Full Summary

Integral Diagnostics Limited (ASX: IDX) announced preliminary FY26 results showing significant growth with revenue expected to be approximately $788m to $790m, up about 25% compared to the previous financial year. Operating EBITDA is expected to be approximately $164m to $165m, up about 30%. The company also announced the appointment of Ms Jenny Martin as its new Chief Financial Officer, who will join on October 5, 2026. Ms Martin brings extensive experience in finance and operations from her previous roles at The Citadel Group Limited and other ASX 200 companies. Mr Craig White, the current CFO, will retire on April 30, 2027, after 4½ years in the role.

Guidance

Revenue: $788m-$790m, EBITDA: $164m-$165m, FY26

Outlook

The company expects continued growth and improvement in financial metrics as it transitions under new leadership.